Literature DB >> 18948269

RalA functions as an indispensable signal mediator for the nutrient-sensing system.

Tomohiko Maehama1, Masahiko Tanaka, Hiroshi Nishina, Makoto Murakami, Yasunori Kanaho, Kentaro Hanada.   

Abstract

Cells sense nutrients present in the extracellular environment and modulate the activities of intracellular signaling systems in response to nutrient availability. This study demonstrates that RalA and its activator RalGDS participate in nutrient sensing and are indispensable for activation of mammalian target of rapamycin complex 1 (mTORC1) induced by extracellular nutrients. Knockdown of RalA or RalGDS abolished amino acid- and glucose-induced mTORC1 activation, as judged by phosphorylation of S6 kinase and eukaryotic translation initiation factor 4E-binding protein 1. The amount of GTP-bound RalA increased in response to increased amino acid availability. In addition, RalA knockdown suppressed Rheb-induced S6 kinase phosphorylation, and the constitutively active form of RalA induced mTORC1 activation in the absence of Rheb. These results collectively suggest that RalGDS and RalA act downstream of Rheb and that RalA activation is a crucial step in nutrient-induced mTORC1 activation.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18948269      PMCID: PMC3259907          DOI: 10.1074/jbc.M805822200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  46 in total

1.  Rheb binds tuberous sclerosis complex 2 (TSC2) and promotes S6 kinase activation in a rapamycin- and farnesylation-dependent manner.

Authors:  Ariel F Castro; John F Rebhun; Geoffrey J Clark; Lawrence A Quilliam
Journal:  J Biol Chem       Date:  2003-07-03       Impact factor: 5.157

2.  RalA but not RalB enhances polarized delivery of membrane proteins to the basolateral surface of epithelial cells.

Authors:  Michail Shipitsin; Larry A Feig
Journal:  Mol Cell Biol       Date:  2004-07       Impact factor: 4.272

3.  The small GTPase RalA targets filamin to induce filopodia.

Authors:  Y Ohta; N Suzuki; S Nakamura; J H Hartwig; T P Stossel
Journal:  Proc Natl Acad Sci U S A       Date:  1999-03-02       Impact factor: 11.205

4.  Amino acid sufficiency and mTOR regulate p70 S6 kinase and eIF-4E BP1 through a common effector mechanism.

Authors:  K Hara; K Yonezawa; Q P Weng; M T Kozlowski; C Belham; J Avruch
Journal:  J Biol Chem       Date:  1998-06-05       Impact factor: 5.157

5.  Dual requirement for a newly identified phosphorylation site in p70s6k.

Authors:  B A Moser; P B Dennis; N Pullen; R B Pearson; N A Williamson; R E Wettenhall; S C Kozma; G Thomas
Journal:  Mol Cell Biol       Date:  1997-09       Impact factor: 4.272

6.  Efficient selection for high-expression transfectants with a novel eukaryotic vector.

Authors:  H Niwa; K Yamamura; J Miyazaki
Journal:  Gene       Date:  1991-12-15       Impact factor: 3.688

7.  Re-evaluating the roles of proposed modulators of mammalian target of rapamycin complex 1 (mTORC1) signaling.

Authors:  Xuemin Wang; Bruno D Fonseca; Hua Tang; Rui Liu; Androulla Elia; Michael J Clemens; Ulrich-Axel Bommer; Christopher G Proud
Journal:  J Biol Chem       Date:  2008-08-01       Impact factor: 5.157

8.  RAL GTPases are linchpin modulators of human tumour-cell proliferation and survival.

Authors:  Yuchen Chien; Michael A White
Journal:  EMBO Rep       Date:  2003-07-11       Impact factor: 8.807

9.  Identification and characterization of Ral-binding protein 1, a potential downstream target of Ral GTPases.

Authors:  S B Cantor; T Urano; L A Feig
Journal:  Mol Cell Biol       Date:  1995-08       Impact factor: 4.272

10.  RalA interacts with ZONAB in a cell density-dependent manner and regulates its transcriptional activity.

Authors:  Paul Frankel; Ami Aronheim; Emma Kavanagh; Maria S Balda; Karl Matter; Tom D Bunney; Christopher J Marshall
Journal:  EMBO J       Date:  2004-12-09       Impact factor: 11.598

View more
  45 in total

Review 1.  Regulation of TOR by small GTPases.

Authors:  Raúl V Durán; Michael N Hall
Journal:  EMBO Rep       Date:  2012-02-01       Impact factor: 8.807

2.  Activating the translational repressor 4E-BP or reducing S6K-GSK3β activity prevents accelerated axon growth induced by hyperactive mTOR in vivo.

Authors:  Xuan Gong; Longbo Zhang; Tianxiang Huang; Tiffany V Lin; Laura Miyares; John Wen; Lawrence Hsieh; Angélique Bordey
Journal:  Hum Mol Genet       Date:  2015-07-28       Impact factor: 6.150

3.  FKBPs and the Akt/mTOR pathway.

Authors:  Felix Hausch; Christian Kozany; Marily Theodoropoulou; Anne-Katrin Fabian
Journal:  Cell Cycle       Date:  2013-07-01       Impact factor: 4.534

Review 4.  Regulation of mTORC1 by PI3K signaling.

Authors:  Christian C Dibble; Lewis C Cantley
Journal:  Trends Cell Biol       Date:  2015-07-06       Impact factor: 20.808

5.  Ral GTPase promotes asymmetric Notch activation in the Drosophila eye in response to Frizzled/PCP signaling by repressing ligand-independent receptor activation.

Authors:  Bomsoo Cho; Janice A Fischer
Journal:  Development       Date:  2011-02-24       Impact factor: 6.868

Review 6.  p62: a versatile multitasker takes on cancer.

Authors:  Jorge Moscat; Maria T Diaz-Meco
Journal:  Trends Biochem Sci       Date:  2012-03-15       Impact factor: 13.807

Review 7.  Role of amino acid transporters in amino acid sensing.

Authors:  Peter M Taylor
Journal:  Am J Clin Nutr       Date:  2013-11-27       Impact factor: 7.045

Review 8.  TOR-dependent control of autophagy: biting the hand that feeds.

Authors:  Thomas P Neufeld
Journal:  Curr Opin Cell Biol       Date:  2009-12-16       Impact factor: 8.382

9.  mTOR Hyperactivity Levels Influence the Severity of Epilepsy and Associated Neuropathology in an Experimental Model of Tuberous Sclerosis Complex and Focal Cortical Dysplasia.

Authors:  Lena H Nguyen; Travorn Mahadeo; Angélique Bordey
Journal:  J Neurosci       Date:  2019-01-30       Impact factor: 6.167

10.  Differential requirement of CAAX-mediated posttranslational processing for Rheb localization and signaling.

Authors:  A B Hanker; N Mitin; R S Wilder; E P Henske; F Tamanoi; A D Cox; C J Der
Journal:  Oncogene       Date:  2009-10-19       Impact factor: 9.867

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.